Literature DB >> 11714795

The amount of scurfin protein determines peripheral T cell number and responsiveness.

R Khattri1, D Kasprowicz, T Cox, M Mortrud, M W Appleby, M E Brunkow, S F Ziegler, F Ramsdell.   

Abstract

In the absence of the recently identified putative transcription factor scurfin, mice develop a lymphoproliferative disorder resulting in death by 3 wk of age from a pathology that resembles TGF-beta or CTLA-4 knockout mice. In this report, we characterize mice that overexpress the scurfin protein and demonstrate that these animals have a dramatically depressed immune system. Mice transgenic for the Foxp3 gene (which encodes the scurfin protein) have fewer T cells than their littermate controls, and those T cells that remain have poor proliferative and cytolytic responses and make little IL-2 after stimulation through the TCR. Although thymic development appears normal in these mice, peripheral lymphoid organs, particularly lymph nodes, are relatively acellular. In a separate transgenic line, forced expression of the gene specifically in the thymus can alter thymic development; however, this does not appear to affect peripheral T cells and is unable to prevent disease in mice lacking a functional Foxp3 gene, indicating that the scurfin protein acts on peripheral T cells. The data indicate a critical role for the Foxp3 gene product in the function of the immune system, with both the number and functionality of peripheral T cells under the aegis of the scurfin protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714795     DOI: 10.4049/jimmunol.167.11.6312

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX).

Authors:  A C Bakke; M Z Purtzer; R S Wildin
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 2.  CD4+ CD25+ Treg: divide and rule?

Authors:  Lucy S K Walker
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

3.  Two histone/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T-regulatory cell development and function.

Authors:  Yujie Liu; Liqing Wang; Rongxiang Han; Ulf H Beier; Tatiana Akimova; Tricia Bhatti; Haiyan Xiao; Philip A Cole; Paul K Brindle; Wayne W Hancock
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

Review 4.  Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  J Mol Med (Berl)       Date:  2006-09-14       Impact factor: 4.599

5.  The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.

Authors:  Philip Brown; Teresa Marafioti; Rajko Kusec; Alison H Banham
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

Review 6.  The role of mucosal T lymphocytes in regulating intestinal inflammation.

Authors:  Holm H Uhlig; Fiona Powrie
Journal:  Springer Semin Immunopathol       Date:  2005-06-15

7.  Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

8.  Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.

Authors:  Estelle Bettelli; Maryam Dastrange; Mohamed Oukka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-24       Impact factor: 11.205

9.  Functional avidity directs T-cell fate in autoreactive CD4+ T cells.

Authors:  Roberto Mallone; Sharon A Kochik; Helena Reijonen; Bryan Carson; Steven F Ziegler; William W Kwok; Gerald T Nepom
Journal:  Blood       Date:  2005-07-19       Impact factor: 22.113

10.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.